Real-World Long-Term Persistence and Surgical Procedure-Free Period Among Bio-na&#xef;ve Patients with Crohn&apos;s Disease and Fistula Initiated on Ustekinumab

Inflammatory Bowel Disease

Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab

Adv Ther

Zhdanava M, Kachroo S, Boonmak P, Burbage S, Shah A, Korsiak J, Lefebvre P, Kerner C, Pilon D

doi: 10.1007/s12325-024-02942-6

Inflammatory Bowel Disease

Efficacy of Ustekinumab and Vedolizumab Among Postoperative Crohn's Disease Patients as Postoperative Prophylaxis and Rescue Therapy: Real-world Data

Inflamm Bowel Dis

Ertem FU, Rivers CR, Ghaffari AA, Watson AR, Tang G, Schwartz M, Johnston E, Barrie A, Harrison J, Dueker JM, Hartman D, Binion DG

doi: 10.1093/ibd/izae137

Inflammatory Bowel Disease

Prolonged time to diagnosis of Crohn's disease in patients with perianal fistulas negatively affects long-term outcomes

J Crohns Colitis

Munster LJ, Pronk AJM, Mundt MW, Hompes R, Bemelman WA, van der Bilt JDW, Buskens CJ

doi: 10.1093/ecco-jcc/jjae146

Inflammatory Bowel Disease

Tofacitinib versus Vedolizumab Among Bio-naïve Patients with Ulcerative Colitis: A Real-World Propensity-Weighted Comparison

J Crohns Colitis

Gros B, Constantine-Cooke N, Kennedy J, Elford AT, O'Hare C, Noble C, Jones GR, Arnott ID, Lees CW, Plevris N

doi: 10.1093/ecco-jcc/jjae188

Inflammatory Bowel Disease

Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease

BMC Gastroenterol

Karki C, Hantsbarger G, Turkstra E, Fenu E, Genenz K, Gilaberte I, Panés J

doi: 10.1186/s12876-024-03513-3

Further Publications

Perianal Disease in Pediatric-Onset Crohn's Disease: Incidence, Disease Course, and Long-Term Outcomes

Clin Gastroenterol Hepatol

Ström A, Jansson S, Wewer MD, Burisch J, Malham M, Wewer V

doi: 10.1016/j.cgh.2025.05.015

Inflammatory Bowel Disease

Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease

Inflamm Bowel Dis

Fumery M, Savoye G, Sarter H, Dupont-Lucas C, Bertrand V, Wils P, Richard N, Guillon N, Gower-Rousseau C, Turck D, Ley D, Leroyer A, EPIMAD group

doi: 10.1093/ibd/izaf133

Inflammatory Bowel Disease

Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients

Inflamm Bowel Dis

Gebeyehu GG, Broglio G, Liu E, Limdi JK, Selinger C, Fiske J, Razanskaite V, Smith PJ, Flanagan PK, Subramanian S

doi: 10.1093/ibd/izae174

Inflammatory Bowel Disease

Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study

Clin Gastroenterol Hepatol

Devi J, Xu A, Stone M, Patel A, Khan A, Reddy N, Klein J, Chowla N, Benson C, Luu BC, Huang K, Jaiprada F, Fenster M, Ungaro R, Pekow J, Johnson AM, Yarur AJ, Shukla R, Huecker J, Bishu S, REBOOT IBD consortium, Deepak P

doi: 10.1016/j.cgh.2025.01.012

Gastroenterology

Real-World Long-Term Persistence and Surgical Procedure-Free Period Among Bio-naïve Patients with Crohn's Disease and Fistula Initiated on Ustekinumab

Related content

Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab

Efficacy of Ustekinumab and Vedolizumab Among Postoperative Crohn's Disease Patients as Postoperative Prophylaxis and Rescue Therapy: Real-world Data

Prolonged time to diagnosis of Crohn's disease in patients with perianal fistulas negatively affects long-term outcomes

Tofacitinib versus Vedolizumab Among Bio-naïve Patients with Ulcerative Colitis: A Real-World Propensity-Weighted Comparison

Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease

Perianal Disease in Pediatric-Onset Crohn's Disease: Incidence, Disease Course, and Long-Term Outcomes

Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease

Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients

Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study